Relation of urinary sodium excretion to blood pressure, glucose metabolism, and lipid metabolism in residents of an area of Japan with high sodium intake.
To evaluate the effects of prolonged intake of a high-sodium diet on glucose and lipid metabolism, we examined the relation of daily urinary sodium excretion to blood pressure, glucose metabolism, and lipid metabolism in 140 Japanese adults who lived in a region where the average daily consumption of sodium was high and stable during the past 15 yr; no subject had received any treatment for hypertension or metabolic disorders. Each subject was admitted to our health examination center for 2 d for measurement of blood pressure, sampling of blood, and glucose tolerance testing. A 24-h urine specimen was collected by each subject after discharge. Multiple regression analysis revealed that urinary sodium excretion was significantly independent of the mean blood pressure and was unrelated to the area under the serum glucose curve after glucose administration. The urinary sodium level was also unrelated to low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol. The prevalence of hypertension in the group with a daily sodium excretion below 140 mEq (low sodium group) was 0%, while that in the group with a daily sodium excretion above 280 mEq (high sodium group) was 44%; this difference was significant (p < 0.01). No significant difference was observed in the prevalence of metabolic disorders between the two groups. Our results suggest that sodium intake has little influence on glucose and lipid metabolism but has a significant influence on blood pressure in normotensive and untreated hypertensive subjects who reside in an area with a relatively high sodium intake.
Kawamura
M
M
Second Department of Internal Medicine, Iwate Medical University, Morioka, Japan.
Kimura
Y
Y
Takahashi
K
K
Satoh
N
N
Oku
K
K
Adachi
T
T
Nakajima
J
J
Murooka
M
M
Fujiwara
T
T
Hiramori
K
K
D000328:Adult; D000367:Age Factors; D000368:Aged; D001786:Blood Glucose / Q000187:drug effects* / Q000378:metabolism*; D001794:Blood Pressure / Q000187:drug effects* / Q000502:physiology*; D015992:Body Mass Index; D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000453:epidemiology / Q000652:urine; D007564:Japan / Q000453:epidemiology; D008055:Lipids / Q000097:blood*; D008297:Male; D008659:Metabolic Diseases / Q000097:blood / Q000453:epidemiology / Q000652:urine*; D008875:Middle Aged; D015999:Multivariate Analysis; D011188:Potassium / Q000652:urine; D012044:Regression Analysis; D012737:Sex Factors; D012964:Sodium / Q000652:urine*; D012982:Sodium, Dietary / Q000008:administration & dosage*; D013997:Time Factors
D001786:Blood Glucose; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008055:Lipids; D012982:Sodium, Dietary; D012964:Sodium; D011188:Potassium